A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus

SIMPLE SUMMARY: Portal vein tumor thrombosis (PVTT) is the commonest type of macrovascular invasion in hepatocellular carcinoma (HCC), while the effectiveness of treatments for HCC with PVTT remains unsatisfactory. The present study aimed to assess the effectiveness of the combination treatment of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zeyu, Li, Chan, Liao, Weijun, Huang, Yun, Wang, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332229/
https://www.ncbi.nlm.nih.gov/pubmed/35892878
http://dx.doi.org/10.3390/cancers14153619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332229/
https://www.ncbi.nlm.nih.gov/pubmed/35892878
http://dx.doi.org/10.3390/cancers14153619

Ejemplares similares